April 7, 2022
Via: FiercePharmaAfter safety concerns derailed an approval of Akebia Therapeutics’ blockbuster hopeful vadadustat late last month, the company warned that a restructuring was in the cards. This week, Akebia telegraphed job cuts for nearly half of its workforce and revealed deeper […]
September 19, 2023
September 14, 2023
September 7, 2023
September 5, 2023
September 20, 2023
September 1, 2023
September 14, 2023
August 30, 2023